Science & Technology
Paley Rothman’s experienced attorneys are uniquely capable of providing today’s technology-based companies with the diverse legal services they require. Our attorneys take a practical problem-solving approach to transactions and negotiations, and we understand the business challenges faced by high-tech clients. We take care to stay abreast of changes and developments in technology licensing and transactions, E-commerce and Internet law, and corporate finance for early-stage businesses. Paley Rothman’s Science and Technology practice group also handles large-scale real estate transactions for technology firms, including highly specialized transactions for biotech companies.
Paley Rothman’s attorneys have negotiated virtually every type of domestic and international licensing agreement on behalf of both licensors and licensees in information technology, pharmaceuticals and biotechnology, as well as many other technology sectors. Many of these licenses are vital parts of broader domestic or international business transactions including toll manufacturing agreements, supply agreements and distribution arrangements. We also routinely establish general and project-specific joint ventures and prepare research and development and related agreements and partnerships, including specialized agreements for electronic game development, design and distribution.
Our attorneys negotiate and draft complex licenses and contracts with clients and service providers for online businesses. Our clients include application service providers, database licensors and virtually all types of professional service firms that deliver services or value-added information to clients through the Internet. We advise clients on E-commerce issues of all types, including disputes over domain names and websites, and we negotiate and litigate these issues when necessary. We also monitor judicial and legislative developments affecting the Internet, such as limits on transmission of copyrighted audio and video, the developing law of online privacy, initiatives relating to identity theft, the Children’s Online Privacy Protection Act, the Electronic Funds Transfer Act, the Uniform Electronic Transactions Act (authorizing use of electronic “signatures”) and many others.
Technology companies cannot survive unless their proprietary technologies are well protected. Paley Rothman’s attorneys frequently prepare specialized confidentiality and non-disclosure agreements, including consulting and employment agreements, which contain measures to protect the value of intellectual property after the end of the relationship. We regularly advise clients on disputes arising from alleged misappropriation of trade secrets and also create defensible, yet practical corporate procedures and guidelines for in-house management of confidential information.
When it comes to attracting the attention of clients and protecting or increasing market share, Paley Rothman understands that a firm’s trademarks are often as valuable as its products and services. We also recognize that copyright registration affords important advantages in protecting against appropriation of valuable intellectual property. Attorneys in the Science and Technology practice group prepare and prosecute trademark applications and work with clients to structure cost-effective copyright registration programs. Our attorneys also counsel clients when disputes arise and have successfully litigated infringement cases to conclusion when needed.
Our experience with many specialized regulatory and licensing requirements as well as with federal, state and local grants and benefits allows us to help clients establish tax-advantaged business organizations that optimally fit their unique needs. This enables us to form and represent technology-based entities ranging from fast-growth startup companies to fully mature regional and national companies. We handle syndications, venture capital placements, leveraged acquisitions and other forms of financing, often working closely with clients to refine business plans in preparation for negotiations with lenders and investors.
Paley Rothman represents major biotechnology, pharmaceutical and chemical manufacturing firms, including several Fortune 500 companies, in the Washington, D.C. metropolitan area, nationally and internationally. Our services include pharmaceutical licensing, regulatory compliance, FIFRA counseling, and structuring and closing synthetic lease financings for cGMP manufacturing facilities and R & D campuses.
August 15, 2018
Paley Rothman is pleased to announce that 16 lawyers have been named to the 2019 Edition of Best Lawyers in America.Read More
On July 30, 2018, the U.S. Equal Employment Opportunity Commission (EEOC) announced a new lawsuit filed in the U.S. District Court for the District of Maryland, Baltimore...Read More
Jeffrey Kolender, Paula Calimafde, and Michelle Chapin were all featured in the most recent edition of the magazine. The feature is in the July/August 2018 edition of Bethesda Magazine. This year, 17 attorneys were listed as the Top Estate Lawyers by their peers, and 8 were selected as Rising Stars.
For the sixth year in a row, Paley Rothman earned national and local honors in US News-Best Lawyers 2018 “Best Law Firms” rankings.
Paley Rothman is pleased to announce that 16 lawyers have been named to the 2018 Edition of Best Lawyers in America. We would like to congratulate the following attorneys named to this year’s list.